Craniocervical Manual Lymphatic Drainage Increases the Efficiency of Atorvastatin-Based Treatment of Chronic Subdural Hematoma

Gao, Chuang; Wei, Yingsheng; Zhang, Xinjie; Huang, Jinhao; Nie, Meng; Liu, Xuanhui; Yuan, Jiangyuan; Wang, Dong; Tian, Ye; Jiang, Weiwei; An, Shuo; Sun, Jian; Sha, Zhuang; Fan, Yanni; Feng, Jiancheng; Liu, Mingqi; Dong, Shiying; Wu, Di; Zhang, Jianning; Wang, Junping; Jiang, Rongcai

doi:10.1007/s12975-022-01062-z

Cited by 4 publications

(1 citation statement)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, MLD has other effects, such as increasing venous flow, reducing fatigue, and raising the pain threshold [22]. Previous studies suggest that craniocervical MLD application is effective in reducing the intracranial pressure [23], promoting chronic subdural hematoma absorption [24]. However, little is known about the effect of craniocervical MLD on moderate TBI.…”

Section: Introductionmentioning

confidence: 99%

The Effect of Craniofacial Manual Lymphatic Drainage after Moderate Traumatic Brain Injury

et al. 2023

View full text Add to dashboard Cite

Previous studies suggest that craniofacial manual lymphatic drainage (MLD) facilitates brain fluids clearance, reducing intracranial pressure and reabsorbing chronic subdural hematoma. This study aimed to explore the effect of craniofacial MLD in combination with pharmacological treatment for improving cranial pain intensity, vital signs, and cerebral edema (Hounsfield units, HUs) in moderate traumatic brain injury (mTBI). Patient 1 received pharmacological therapy, while patient 2 received both pharmacological and craniocervical MLD treatment. Patient 2 showed decreased cranial pain intensity and systolic blood pressure (66%–11.11%, respectively) after two 30 min daily sessions of treatment for three days. HUs in the caudate nucleus of both hemispheres (left 24.64%–right 28.72%) and in the left temporal cortical gray matter increased (17.8%). An increase in HU suggests a reduction in cerebral edema and vice versa. For patient 1, there were no changes in cranial pain intensity, but a slight increase in the systolic blood pressure was observed (0%–3.27%, respectively). HUs decreased in the temporal cortical (14.98%) and caudate nucleus gray matter (9.77%) of the left and right cerebral hemispheres (11.96%–16.74%, respectively). This case study suggests that craniofacial MLD combined with pharmacological treatment could reduce cerebral edema, decrease head pain intensity, and maintain vital signs in normal physiologic values in patients with mTBI.

show abstract

Section: Introductionmentioning

confidence: 99%